|
⚲
|
| Keyboard |
| Fisher Douglas Carl
✚
|
|
|---|---|
| CIK # | 0001572355 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001572355] | |
| 4 | [0001572355] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CERO Therapeutics Holdings Inc CERO
Class A Common Stock
|
2024-02-14 | Other | 43,300 | ||
|
CERO Therapeutics Holdings Inc CERO
Warrants · derivative
|
2024-02-14 | Other | 5,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-02-14 | Grant | 50 | $1,000.00 | 50,000 |
|
Transgenomic Inc PRPO
Common Stock
|
2023-10-27 | Grant | 5,174 | ||
|
Transgenomic Inc PRPO
Common Stock
|
2023-09-12 | Grant | 7,954 | ||
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2023-01-06 | Grant | 30,000 | ||
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2022-01-11 | Grant | 40,000 | ||
|
CERO Therapeutics Holdings Inc PBAX
Warrants · derivative
|
2021-10-08 | Other | 5,000 | ||
|
CERO Therapeutics Holdings Inc PBAX
Class A common stock
|
2021-10-08 | Other | 10,000 | ||
|
CERO Therapeutics Holdings Inc PBAX
Class B Common Stock · derivative
|
2021-10-08 | Other | 100,000 | ||
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2021-08-03 | Grant | 25,000 | ||
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2021-01-04 | Grant | 25,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option · derivative
|
2020-09-16 | Grant | 27,250 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2020-09-16 | Grant | 27,250 | $0.00 | |
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2020-07-02 | Grant | 4,000 | ||
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2020-01-16 | Grant | 7,500 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock (Restricted Stock Units)
|
2019-07-23 | Grant | 78,125 | $0.00 | |
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2019-03-18 | Grant | 75,000 | ||
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2018-06-13 | Grant | 81,774 | $0.00 | |
|
Transgenomic Inc PRPO
Stock Option (Right to Buy) · derivative
|
2018-02-16 | Grant | 31,025 | $0.00 | |
| showing 20 of 26 most recent transactions | |||||